Breaking

Breaking

news-23102024-213801

Examining the Controversy Surrounding Racial Health Disparities Study

Have you ever heard of the concept of sorting celebrities into "Whos" and "Thems"? It's an interesting way to categorize famous people based on their level of fame. When it comes to the five...
news-23102024-153231

Assessing the Cost-Effectiveness of Alzheimer’s Drug Donanemab in the U.K.

The recent decision by the U.K.'s National Institute for Health and Care Excellence (NICE) regarding the cost-effectiveness of the Alzheimer's drug Donanemab, also known as Kisunla, has raised concerns about its accessibility to patients....
news-23102024-093106

Healthy Eating: Emphasizing Fruits and Vegetables for Better Nutrition

Food science faces a significant challenge when it comes to providing scientific certainty. This is because people consume foods, not isolated nutrients. The experts responsible for advising federal health officials on the 2025-2030 Dietary...
news-23102024-032937

FDA Petitioned to Prevent Compounders from Producing Ozempic Generics

Novo Nordisk, the pharmaceutical company, has requested the Food and Drug Administration (FDA) to stop compounding pharmacies from producing generic versions of its popular weight loss drug semaglutide. The company believes that the medication...
news-22102024-212802

Bipartisan Support for Strengthening Addiction Treatment in Washington D.C.

Today, we're diving into the latest healthcare and policy news, straight from D.C. Diagnosis, STAT's newsletter. As we navigate through a tumultuous election season, it's always nice to find some solace in shows like...
news-22102024-152639

Senators Seek Clarity on Pfizer and Eli Lilly’s Telehealth Platforms

Senators, including Sen. Dick Durbin, are calling on Pfizer and Eli Lilly to provide more information about their partnerships with telehealth providers. These pharmaceutical companies recently launched websites that offer users information about their...
news-22102024-092456

Pharma Executives Increase Donations to Democrats Before Election Day

During the final stretch of the 2024 campaign, pharmaceutical company executives have not been very active in donating directly to political candidates. However, those who did donate mostly chose to support Democratic candidates. Out...
news-22102024-032124

Navigating Ultra-Processed Foods: Dietary Experts’ Advice

Scientific experts working on the development of the 2025-2030 Dietary Guidelines for Americans recently discussed the challenges of including ultra-processed foods due to a lack of a clear definition and limited scientific research on...
news-21102024-212010

Why Requiring Presidents and Candidates to Share Medical History is a Bad Idea

Kamala Harris recently shared some of her medical information and urged Donald Trump to do the same, sparking a debate about whether presidential candidates should be required to disclose their medical records. However, George...
news-21102024-151856

Catalent’s Deal with Novo Holdings: Customer Reassurance and Updates

Catalent, a major contract drug manufacturer, recently reassured its customers through an open letter that its proposed acquisition by Novo Nordisk’s parent company for $16.5 billion would not impact its ability to provide services...
news-21102024-091557

Seaport Therapeutics Secures $225 Million to Advance Neuroscience Innovation in the ‘Golden Age’

Seaport Therapeutics, a new biotech startup led by the team from Karuna Therapeutics, has successfully secured an additional $225 million in funding just half a year after its last fundraising effort. The Series B...
news-21102024-031419

Creating a ‘Golden Record’ for Medicine: D.A. Wallach on Coping with Tragic Loss

D.A. Wallach shared a deeply personal story at the 2024 STAT Summit in Boston, revealing how the tragic loss of his wife inspired him to advocate for change in the U.S. health system. He...

BREAKING NEWS

Top News